Last Updated: September 26, 2023 @ 9:13 am | ||
1152 | Factor V Leiden | |
Specimen: | Collect: |
Also Acceptable:
|
Submit: |
Also Acceptable:
| |
Special Handling: |
| |
Rejection Criteria: |
| |
Stability: | Ambient: Unacceptable; Refrigerated: 1 Month(s); Frozen: Unacceptable; Incubated: Unacceptable | |
Methodology: |
| |
Performed: | Wednesday | |
Reported: | 1-7 Day(s) | |
CPT Codes: |
| |
Interpretive Data: | General Reference Range : negative Where appropriate, medical consultation and/or genetic counseling should be offered to patients to inform and explain the risk implications and genetic implications of these test results. Patient DNA is assayed for the Factor V Leiden G1691A mutation by polymerase chain reaction (PCR) and MOLDI-TOF mass spectrometry technology. The product of PCR is detected on the Agena Bioscience MassARRAY system. Other causes of activated protein C resistance and hereditary forms of venous thrombosis are not ruled out. The test result must be interpreted along with the patient's clinical history and other pertinent laboratory data. Variant analyzed: c.1601G>A (p.Arg534Gln), referred to as Factor V Leiden. | |
Components: |
|
Disclaimer:
It is preferable to locate tests on the website and not rely on printed test information, which may soon be out of date.
Updated test information can only be guaranteed by using this website.